3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Withdrawn
1
Recruiting
1
Not yet recruiting
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Breast Neoplasms
33
Neoplasms
25
Prostatic Neoplasms
16
Colorectal Neoplasms
13
Lung Neoplasms
11
Multiple Myeloma
9
Head and Neck Neoplasms
8
Carcinoma, Non-Small-Cell Lung
8
Pancreatic Neoplasms
6
Neoplasm Metastasis
6
Urinary Bladder Neoplasms
5
Hematologic Neoplasms
5
Gastrointestinal Neoplasms
5
Advanced Cancer
5
Uterine Cervical Neoplasms
4
Smoking Cessation
4
Ovarian Neoplasms
4
Melanoma
4
Leukemia
4
Colonic Neoplasms
4
Anxiety Disorders
4
Triple Negative Breast Neoplasms
3
Stomach Neoplasms
3
Small Cell Lung Carcinoma
3
Recurrence
3
Rectal Neoplasms
3
Neoplasms, Plasma Cell
3
Motor Activity
3
Lymphoma, Follicular
3
Lymphedema
3
Interventions
Carboplatin
27
Paclitaxel
24
Cisplatin
22
Gemcitabine
17
pembrolizumab
15
Fluorouracil
9
Docetaxel
9
Pemetrexed
8
Everolimus
8
Cetuximab
8
Radiotherapy, Intensity-Modulated
7
Radiotherapy
7
Nivolumab
7
130-nm albumin-bound paclitaxel
7
Sorafenib
6
Bevacizumab
6
Axitinib
6
epothilone B
5
Sunitinib
5
Radiation
5
Panitumumab
5
Irinotecan
5
Cyclophosphamide
5
trebananib
4
reolysin
4
padeliporfin
4
lenvatinib
4
Gefitinib
4
Albumin-Bound Paclitaxel
4
vosaroxin
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Carcinoma
×
Standard of Care
×
Clear all
NCT01529411
2019-04-04
MAJA
Spanish Oncology Genito-Urinary Group
Phase 2
Completed
86 enrolled